文献速递精神分裂症与精神病性障碍儿童青少年精神心境障碍

新生儿维生素D状态与神经发育障碍风险的汇聚证据:丹麦病例-队列研究

Convergent evidence linking neonatal vitamin D status and risk of neurodevelopmental disorders: a Danish case-cohort study.
PubMed 文献 · Lancet Psychiatry · 2025-01-01

该研究基于丹麦1981-2005年出生人群的病例-队列样本,检测新生儿干血斑中25(OH)D和DBP浓度,发现25(OH)D与精神分裂症、ASD和ADHD风险呈显著负相关,DBP与精神分裂症风险呈负相关,孟德尔随机化支持低25(OH)D和DBP与ADHD风险增加存在因果关联。

要点

  • 新生儿25(OH)D水平越高,精神分裂症、ASD和ADHD风险越低。
  • 新生儿DBP水平越高,精神分裂症风险越低。
  • 孟德尔随机化支持低25(OH)D和DBP与ADHD风险增加存在因果关联。

核心结论

  • 汇聚证据表明新生儿维生素D状态与多种精神障碍风险改变相关,优化新生儿维生素D状态或可降低神经发育障碍发病率。

研究设计与样本

  • 基于丹麦1981-2005年出生人群的病例-队列研究,纳入iPSYCH2012设计总人群n=88 764,并随机抽取子队列n=30 000。
  • 基于新生儿干血斑测量25(OH)D和DBP浓度,随访至2012年12月31日,以ICD-10诊断六种精神障碍。

主要发现

  • 25(OH)D与精神分裂症风险呈显著负相关(HR 0·82,95% CI 0·78-0·86)。
  • 25(OH)D与ASD风险呈显著负相关(HR 0·93,95% CI 0·90-0·96)。
  • 25(OH)D与ADHD风险呈显著负相关(HR 0·89,95% CI 0·86-0·92)。
  • DBP与精神分裂症风险呈显著负相关(HR 0·84,95% CI 0·80-0·88)。
  • 基于多基因风险评分,较高25(OH)D浓度(校正DBP后)与ASD和精神分裂症风险降低显著相关;孟德尔随机化支持低25(OH)D和DBP浓度与ADHD风险增加存在因果关联。

关键数值与推荐

  • 在符合纳入标准(如已测25(OH)D、DBP或基因型,且主要为欧洲血统)的个体中,71 793人测定了25(OH)D或DBP(男38 118人[53·1%],女33 675人[46·9%]),其中65 952人测25(OH)D,66 797人测DBP。

临床怎么用

  • 临床可关注新生儿维生素D状态作为神经发育障碍风险的潜在可干预因素。
  • 对新生儿维生素D水平的评估或有助于识别精神分裂症、ASD和ADHD高风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is growing evidence linking neonatal vitamin D deficiency to an increased risk of schizophrenia, ADHD, and autism spectrum disorder (ASD). The aim of this study was to examine the association between two vitamin D biomarkers (25 hydroxyvitamin D [25(OH)D] and vitamin D-binding protein [DBP], and their related genetic correlates) and the risk of six mental disorders. METHODS: We used a population-based, case-cohort sample of all individuals born in Denmark between 1981 and 2005. Using Danish health registers with follow-up to Dec 31, 2012, we identified individuals diagnosed with major depressive disorder, bipolar disorder, schizophrenia, ADHD, ASD, and anorexia nervosa based on ICD-10 criteria. Additionally, a random subcohort from the general population was selected. Based on neonatal dried blood spots, we measured concentrations of 25(OH)D and DBP. Our primary analyses were based on hazard ratios (HR) with 95% CI and absolute risks for the six mental disorders according to measured concentrations of 25(OH)D and DBP. As secondary analyses, we examined the association between genetic predictors of 25(OH)D and DBP, and the six mental disorders, and Mendelian randomisation analyses based on published summary statistics for 25(OH)D, DBP, and the six mental disorders. People with lived experience contributed to the development of the guiding hypothesis. FINDINGS: We used the total population from the iPSYCH2012 design (n=88 764), which included individuals who developed the six mental disorders, major depressive disorder (n=24 240), bipolar disorder (n=1928), schizophrenia (n=3540), ADHD (n=18 726), ASD (n=16 146), anorexia nervosa (n=3643), and the randomly sampled subcohort (n=30 000). Among those who met a range of inclusion criteria (eg, measured 25[OH]D, DBP or genotype, and predominantly European ancestry), we measured 25(OH)D or DBP in 71 793 individuals (38 118 [53·1%] male and 33 675 [46·9%] female); 65 952 had 25(OH)D and 66 797 the DBP measurements. Significant inverse relationships were found between 25(OH)D and schizophrenia (HR 0·82, 95% CI 0·78-0·86), ASD (HR 0·93, 95% CI 0·90-0·96), and ADHD (HR 0·89, 95% CI 0·86-0·92). A significant inverse relationship was found between DBP and schizophrenia (HR 0·84, 95% CI 0·80-0·88). Based on polygenic risk scores, higher concentrations of 25(OH)D (adjusted for DBP) were significantly associated with a reduced risk of both ASD and schizophrenia. Analyses based on Mendelian randomisation provided support for a causal association between both lower 25(OH)D and DBP concentrations and an increased risk of ADHD. INTERPRETATION: Convergent evidence finds that neonatal vitamin D status is associated with an altered risk of mental disorders. Our study supports the hypothesis that optimising neonatal vitamin D status might reduce the incidence of a range of neurodevelopmental disorders. FUNDING: The Danish National Research Foundation.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Horsdal HT, Albiñana C, Zhu Z, et al. Convergent evidence linking neonatal vitamin D status and risk of neurodevelopmental disorders: a Danish case-cohort study. Lancet Psychiatry. 2025. PMID: 40379361. doi:10.1016/S2215-0366(25)00099-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。